Literature DB >> 17387320

'Insignificant' prostate cancer on biopsy: pathologic results from subsequent radical prostatectomy.

P A S Johnstone1, P J Rossi, A B Jani, V Master.   

Abstract

'Insignificant' prostate cancer is defined as disease of virulence insufficient to threaten survival. In this review, which describes nine articles and two abstracts discussing almost 800 cases, we discuss the correlation of such 'insignificant' biopsy findings in the context of subsequent radical prostatectomy data. From our review, minimal disease on biopsy does not reliably predict minimal disease in the subsequent prostatectomy specimen, in terms of the size and grade of tumor, extracapsular extension or positive margins. Thus, reasoned accounting should be made of other data before undertaking a course of radiation therapy as monotherapy, particularly prostate-specific antigen kinetics and potential molecular markers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17387320     DOI: 10.1038/sj.pcan.4500963

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  7 in total

1.  Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer.

Authors:  Ralph W deVere White; Alexander Tsodikov; Eschelle C Stapp; Stephanie E Soares; Hajime Fujii; Robert M Hackman
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

Review 2.  Pathologic basis of focal therapy for early-stage prostate cancer.

Authors:  Vladimir Mouraviev; Janice M Mayes; Thomas J Polascik
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

Review 3.  Aberrant PSA glycosylation--a sweet predictor of prostate cancer.

Authors:  Sarah Gilgunn; Paul J Conroy; Radka Saldova; Pauline M Rudd; Richard J O'Kennedy
Journal:  Nat Rev Urol       Date:  2013-01-15       Impact factor: 14.432

4.  Sampling the spatial patterns of cancer: optimized biopsy procedures for estimating prostate cancer volume and Gleason Score.

Authors:  Yangming Ou; Dinggang Shen; Jianchao Zeng; Leon Sun; Judd Moul; Christos Davatzikos
Journal:  Med Image Anal       Date:  2009-05-23       Impact factor: 8.545

Review 5.  The Study of Active Monitoring in Sweden (SAMS): a randomized study comparing two different follow-up schedules for active surveillance of low-risk prostate cancer.

Authors:  Ola Bratt; Stefan Carlsson; Erik Holmberg; Lars Holmberg; Eva Johansson; Andreas Josefsson; Annika Nilsson; Maria Nyberg; David Robinsson; Jonas Sandberg; Dag Sandblom; Pär Stattin
Journal:  Scand J Urol       Date:  2013-07-24       Impact factor: 1.612

6.  Comparison of transperineal mapping biopsy results with whole-mount radical prostatectomy pathology in patients with localized prostate cancer.

Authors:  Darren J Katz; Rodrigo Pinochet; Kyle A Richards; Guilherme Godoy; Kazuma Udo; Lucas Nogueira; Angel M Cronin; Samson W Fine; Peter T Scardino; Jonathon A Coleman
Journal:  Prostate Cancer       Date:  2014-05-11

Review 7.  Schema and cancer detection rates for transperineal prostate biopsy templates: a review.

Authors:  Abhinav Sidana; Fernando Blank; Hannah Wang; Nilesh Patil; Arvin K George; Hasan Abbas
Journal:  Ther Adv Urol       Date:  2022-06-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.